Importantly, no differences were observed in the expression of any of these proteins or in the effect of AZD5363 on this expression between CLL samples that were responsive or unresponsive to the anti-proliferative effects of AKT inhibition. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.